西北地区STEMI患者溶栓后区域转运联合PCI模式的安全性与有效性
结果显示溶栓联合PCI组发病至首次医疗接触及再灌注时间更短,全因死亡发生率更低,出血、缺血性卒中及恶性心律失常无显著差异,提示该模式可行有效。
要点
- 溶栓联合PCI组再灌注时间显著短于直接PCI组。
- 溶栓联合PCI组全因死亡发生率低于直接PCI组。
- 两组出血、缺血性卒中及恶性心律失常发生率无显著差异。
核心结论
- 对于首诊于非PCI医院的STEMI患者,溶栓后区域转运联合PCI策略不显著增加出血及心脑血管事件风险,且可缩短心肌再灌注时间,该模式可行有效。
主要发现
- 直接PCI组术前TIMI血流0级比例显著高于溶栓联合PCI组[63.0%(518/822)比36.3%(87/240),P<0.001]。
- 溶栓联合PCI组发病至首次医疗接触时间短于直接PCI组[2.11(1.00,4.00)h比3.00(1.13,7.07)h,P<0.001]。
- 溶栓联合PCI组发病至再灌注治疗时间短于直接PCI组[3.07(1.83,4.87)h比6.92(4.07,11.15)h,P<0.001]。
- 直接PCI组全因死亡发生率高于溶栓联合PCI组[1.8%(15/822)比0,P=0.03]。
- 两组出血事件、缺血性卒中及恶性心律失常发生率差异无统计学意义(P均>0.05)。
关键数值与推荐
- 观察终点包括全因死亡、缺血性卒中、恶性心律失常、颅内出血及血红蛋白下降程度≥50 g/L的出血。
临床怎么用
- 对于首诊于非PCI医院的STEMI患者,可考虑溶栓后区域转运至PCI医院联合PCI治疗,以缩短再灌注时间且不增加出血及心脑血管事件风险。
局限性
- 本研究为单中心回顾性研究,结果需进一步前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the safety and efficacy of regional transport to percutaneous coronary intervention(PCI) hospitals from non-PCI hospitals after thrombolysis in patients with acute ST-segment elevation myocardial infarction(STEMI) in northwest China. Methods: In this retrospective study, 1 062 STEMI patients who were transferred from non-PCI hospitals within 24 hours from symptom onset, during January 2015 and January 2019 in the First Hospital of Lanzhou University, were included. According to the treatment strategy, they were divided into two groups, namely intravenous thrombolysis combined with PCI group(n=240), and primary PCI group(n=822). Observation endpoint were in-hospital adverse cardiovascular and cerebrovascular events and bleeding events, Including all-cause death, ischemic stroke, malignant arrhythmia, intracranial hemorrhage and hemorrhage with hemoglobin decrease≥50 g/L. Results: A total of 1 062 STEMI patients were included(age was (61±12) years old), with 905 males (85.2%). The proportion of grade 0 TIMI blood flow in the primary PCI group before operation was significantly higher than that in the thrombolysis combined with PCI group(63.0%(518/822) vs. 36.3%(87/240), P<0.001). Compared with primary PCI group, the time from symptom onset to first medical contact(2.11(1.00, 4.00)hours vs.3.00(1.13, 7.07)hours, P<0.001) and reperfusion in thrombolysis combined with PCI group(3.07(1.83, 4.87)hours vs. 6.92(4.07, 11.15) hours, P<0.001) were significantly shorter. The proportion of all-cause death was significantly higher in the primary PCI group than that in the thrombolysis combined with PCI group (1.8%(15/822) vs. 0, P=0.03). There was no significant difference in hemorrhage, ischemic stroke and malignant arrhythmia between the two groups(all P>0.05). Conclusions: For STEMI patients initially hospitalized in non-PCI hospitals, regional transport combined with PCI is feasible and effective. It does not significantly increase the risk of bleeding and cardiovascular and cerebrovascular events, with shorter time from symptom onset to myocardial reperfusion. 目的: 探讨西北地区急性ST段抬高型心肌梗死(STEMI)患者在非经皮冠状动脉介入治疗(PCI)医院溶栓后区域转运至PCI医院模式的安全性及有效性。 方法: 本研究为回顾性研究,连续纳入了自2015年1月至2019年1月兰州大学第一医院胸痛中心收治的,由基层医院转诊来的、发病时间<24 h的STEMI患者1 062例,根据治疗策略分为静脉溶栓联合PCI组(240例)和直接PCI组(822例)。观察终点为患者院内不良心脑血管事件及出血事件,包括全因死亡、缺血性卒中、恶性心律失常、颅内出血及血红蛋白下降程度≥50 g/L的出血。 结果: 本研究共纳入STEMI患者1 062例,年龄(61±12)岁,其中男性905例(85.2%)。直接PCI组患者的术前心肌梗死溶栓试验(TIMI)血流0级者比例明显高于静脉溶栓联合PCI组[63.0%(518/822)比36.3%(87/240),P<0.001]。与直接PCI组比较,溶栓联合PCI组患者从发病至首次医疗接触[2.11(1.00,4.00)h比3.00(1.13,7.07)h,P<0.001]及接受再灌注治疗[3.07(1.83,4.87)h比6.92(4.07,11.15)h,P<0.001]时间更短。直接PCI组的全因死亡发生率高于静脉溶栓联合PCI组[1.8%(15/822)比0,P=0.03];两组的出血事件、缺血性卒中及恶性心律失常发生率差异无统计学意义(P均>0.05)。 结论: 就诊于非PCI医院的STEMI患者,溶栓后区域转运联合PCI的策略不显著增加出血及心脑血管事件发生风险,且可有效缩短心肌再灌注时间。溶栓后区域转运联合PCI模式可行、有效。.
引用
- Bai M, Pan CL, Zhao J, et al. [Safety and efficacy of regional transport combined with PCI model in patients with STEMI after thrombolysis in northwest China]. Zhonghua Xin Xue Guan Bing Za Zhi. 2020. PMID: 32847319. doi:10.3760/cma.j.cn112148-20200228-00138
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。